Literature DB >> 21351746

Aminothiazolomorphinans with mixed κ and μ opioid activity.

Tangzhi Zhang1, Zhaohua Yan, Anna Sromek, Brian I Knapp, Thomas Scrimale, Jean M Bidlack, John L Neumeyer.   

Abstract

A series of N-substituted and N'-substituted aminothiazole-derived morphinans (5) were synthesized for expanding the structure-activity relationships of aminothiazolo-morphinans. Although their affinities were somewhat lower than their prototype aminothiazolo-N-cyclopropylmorphinan (3), 3-aminothiazole derivatives of cyclorphan (1) containing a primary amino group displayed high affinity and selectivity at the κ and μ opioid receptors. [(35)S]GTPγS binding assays showed that the aminothiazolomorphinans were κ agonists with mixed agonist and antagonist activity at the μ opioid receptor. These novel N'-monosubstituted aminothiazole-derived morphinans may be valuable for the development of drug abuse medications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21351746      PMCID: PMC3068608          DOI: 10.1021/jm101542c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.

Authors:  J L Neumeyer; X H Gu; L A van Vliet; N J DeNunzio; D E Rusovici; D J Cohen; S S Negus; N K Mello; J M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2001-10-22       Impact factor: 2.823

2.  Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys.

Authors:  Carrie A Bowen; S Stevens Negus; Rushi Zong; John L Neumeyer; Jean M Bidlack; Nancy K Mello
Journal:  Neuropsychopharmacology       Date:  2003-03-05       Impact factor: 7.853

3.  Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.

Authors:  J L Neumeyer; J M Bidlack; R Zong; V Bakthavachalam; P Gao; D J Cohen; S S Negus; N K Mello
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

4.  Low molecular weight non-peptide mimics of omega-conotoxin GVIA.

Authors:  Peter J Duggan; Richard J Lewis; Y Phei Lok; Natalie G Lumsden; Kellie L Tuck; Aijun Yang
Journal:  Bioorg Med Chem Lett       Date:  2009-03-28       Impact factor: 2.823

5.  Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.

Authors:  V I Chefer; J A Morón; B Hope; W Rea; T S Shippenberg
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration.

Authors:  S Schenk; B Partridge; T S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2001-04       Impact factor: 7.853

7.  Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse.

Authors:  J L Neumeyer; N K Mello; S S Negus; J M Bidlack
Journal:  Pharm Acta Helv       Date:  2000-03

8.  Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.

Authors:  Yu-Jun Wang; Yi-Min Tao; Fu-Ying Li; Yu-Hua Wang; Xue-Jun Xu; Jie Chen; Ying-Lin Cao; Zhi-Qiang Chi; John L Neumeyer; Ao Zhang; Jing-Gen Liu
Journal:  J Pharmacol Exp Ther       Date:  2009-01-09       Impact factor: 4.030

9.  Microwave-promoted Pd-catalyzed cyanation of aryl triflates: a fast and versatile access to 3-cyano-3-desoxy-10-ketomorphinans.

Authors:  Ao Zhang; John L Neumeyer
Journal:  Org Lett       Date:  2003-01-23       Impact factor: 6.005

10.  10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.

Authors:  Ao Zhang; Wennan Xiong; Jean M Bidlack; James E Hilbert; Brian I Knapp; Mark P Wentland; John L Neumeyer
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

View more
  5 in total

1.  Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.

Authors:  John L Neumeyer; Bin Zhang; Tangzhi Zhang; Anna W Sromek; Brian I Knapp; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2012-04-04       Impact factor: 7.446

2.  Copper-Catalyzed Electrophilic Amination of Heteroaromatic and Aromatic C-H Bonds via TMPZnCl•LiCl Mediated Metalation.

Authors:  Stacey L McDonald; Charles E Hendrick; Katie J Bitting; Qiu Wang
Journal:  Organic Synth       Date:  2015-11-17

Review 3.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

4.  Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors.

Authors:  Brian A Provencher; Anna W Sromek; Wei Li; Shayla Russell; Elena Chartoff; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2013-10-29       Impact factor: 7.446

5.  Copper-catalyzed electrophilic amination of heteroarenes and arenes by C-H zincation.

Authors:  Stacey L McDonald; Charles E Hendrick; Qiu Wang
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-25       Impact factor: 15.336

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.